vs
艾伯维（ARGX）与艾利丹尼森（AVY）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是艾利丹尼森的1.1倍（$2.5B vs $2.3B），艾伯维净利率更高（35.5% vs 7.3%，领先28.2%），艾伯维同比增速更快（83.2% vs 7.0%），艾伯维自由现金流更多（$322.4M vs $104.4M）
艾伯维是总部位于美国伊利诺伊州北芝加哥的制药企业，研发生产的药物覆盖多种疾病治疗领域，可满足多元临床需求，致力于为全球不同病症的患者提供可靠的治疗方案选择。
艾利丹尼森是总部位于美国俄亥俄州门托市的财富500强跨国企业，专业从事压敏胶材料、服装品牌标签吊牌、RFID嵌体及特种医疗产品的生产与分销，业务覆盖全球多个主要市场。
ARGX vs AVY — 直观对比
营收规模更大
ARGX
是对方的1.1倍
$2.3B
营收增速更快
ARGX
高出76.2%
7.0%
净利率更高
ARGX
高出28.2%
7.3%
自由现金流更多
ARGX
多$218.0M
$104.4M
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.5B | $2.3B |
| 净利润 | $877.2M | $168.1M |
| 毛利率 | 89.5% | 28.9% |
| 营业利润率 | 28.9% | 10.7% |
| 净利率 | 35.5% | 7.3% |
| 营收同比 | 83.2% | 7.0% |
| 净利润同比 | 1.3% | 1.1% |
| 每股收益（稀释后） | $13.25 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARGXAVY
| Q1 26 | — | $2.3B | ||
| Q4 25 | $2.5B | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $1.8B | $2.2B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $1.4B | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | $901.9M | $2.2B |
净利润ARGXAVY
| Q1 26 | — | $168.1M | ||
| Q4 25 | $877.2M | $166.4M | ||
| Q3 25 | — | $166.3M | ||
| Q2 25 | $414.8M | $189.0M | ||
| Q1 25 | — | $166.3M | ||
| Q4 24 | $865.6M | $174.0M | ||
| Q3 24 | — | $181.7M | ||
| Q2 24 | $-32.5M | $176.8M |
毛利率ARGXAVY
| Q1 26 | — | 28.9% | ||
| Q4 25 | 89.5% | 28.7% | ||
| Q3 25 | — | 28.7% | ||
| Q2 25 | 89.2% | 28.8% | ||
| Q1 25 | — | 28.9% | ||
| Q4 24 | 90.2% | 27.9% | ||
| Q3 24 | — | 28.7% | ||
| Q2 24 | 89.4% | 29.6% |
营业利润率ARGXAVY
| Q1 26 | — | 10.7% | ||
| Q4 25 | 28.9% | 9.1% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | 19.2% | 11.5% | ||
| Q1 25 | — | 10.6% | ||
| Q4 24 | 8.7% | 11.0% | ||
| Q3 24 | — | 11.0% | ||
| Q2 24 | -15.4% | 10.7% |
净利率ARGXAVY
| Q1 26 | — | 7.3% | ||
| Q4 25 | 35.5% | 7.3% | ||
| Q3 25 | — | 7.5% | ||
| Q2 25 | 23.4% | 8.5% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | 64.1% | 8.0% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | -3.6% | 7.9% |
每股收益（稀释后）ARGXAVY
| Q1 26 | — | — | ||
| Q4 25 | $13.25 | $2.16 | ||
| Q3 25 | — | $2.13 | ||
| Q2 25 | $6.32 | $2.41 | ||
| Q1 25 | — | $2.09 | ||
| Q4 24 | $13.33 | $2.17 | ||
| Q3 24 | — | $2.25 | ||
| Q2 24 | $-0.55 | $2.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5B | $255.1M |
| 总债务越低越好 | — | $3.2B |
| 股东权益账面价值 | $7.3B | $2.3B |
| 总资产 | $8.7B | $9.0B |
| 负债/权益比越低杠杆越低 | — | 1.38× |
8季度趋势，按日历期对齐
现金及短期投资ARGXAVY
| Q1 26 | — | $255.1M | ||
| Q4 25 | $3.5B | $202.8M | ||
| Q3 25 | — | $536.3M | ||
| Q2 25 | $2.1B | $215.9M | ||
| Q1 25 | — | $195.9M | ||
| Q4 24 | $1.5B | $329.1M | ||
| Q3 24 | — | $212.7M | ||
| Q2 24 | $1.4B | $208.8M |
总债务ARGXAVY
| Q1 26 | — | $3.2B | ||
| Q4 25 | — | $3.2B | ||
| Q3 25 | — | $3.2B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $11.0M | $2.0B |
股东权益ARGXAVY
| Q1 26 | — | $2.3B | ||
| Q4 25 | $7.3B | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $6.1B | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | $5.5B | $2.3B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | $4.3B | $2.3B |
总资产ARGXAVY
| Q1 26 | — | $9.0B | ||
| Q4 25 | $8.7B | $8.8B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | $7.2B | $8.6B | ||
| Q1 25 | — | $8.4B | ||
| Q4 24 | $6.2B | $8.4B | ||
| Q3 24 | — | $8.5B | ||
| Q2 24 | $4.8B | $8.3B |
负债/权益比ARGXAVY
| Q1 26 | — | 1.38× | ||
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | — | 1.19× | ||
| Q1 25 | — | 1.19× | ||
| Q4 24 | — | 1.11× | ||
| Q3 24 | — | 0.85× | ||
| Q2 24 | 0.00× | 0.89× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $323.3M | — |
| 自由现金流经营现金流 - 资本支出 | $322.4M | $104.4M |
| 自由现金流率自由现金流/营收 | 13.0% | 4.5% |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 0.37× | — |
| 过去12个月自由现金流最近4个季度 | $594.5M | $869.1M |
8季度趋势，按日历期对齐
经营现金流ARGXAVY
| Q1 26 | — | — | ||
| Q4 25 | $323.3M | $376.8M | ||
| Q3 25 | — | $312.1M | ||
| Q2 25 | $361.8M | $208.8M | ||
| Q1 25 | — | $-16.3M | ||
| Q4 24 | $41.9M | $351.2M | ||
| Q3 24 | — | $270.1M | ||
| Q2 24 | $-124.7M | $197.7M |
自由现金流ARGXAVY
| Q1 26 | — | $104.4M | ||
| Q4 25 | $322.4M | $309.7M | ||
| Q3 25 | — | $276.2M | ||
| Q2 25 | $356.6M | $178.8M | ||
| Q1 25 | — | $-52.3M | ||
| Q4 24 | $40.9M | $281.7M | ||
| Q3 24 | — | $227.1M | ||
| Q2 24 | $-125.5M | $150.2M |
自由现金流率ARGXAVY
| Q1 26 | — | 4.5% | ||
| Q4 25 | 13.0% | 13.6% | ||
| Q3 25 | — | 12.5% | ||
| Q2 25 | 20.1% | 8.1% | ||
| Q1 25 | — | -2.4% | ||
| Q4 24 | 3.0% | 12.9% | ||
| Q3 24 | — | 10.4% | ||
| Q2 24 | -13.9% | 6.7% |
资本支出强度ARGXAVY
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 3.0% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | 0.3% | 1.4% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | 0.1% | 3.2% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | 0.1% | 2.1% |
现金转化率ARGXAVY
| Q1 26 | — | — | ||
| Q4 25 | 0.37× | 2.26× | ||
| Q3 25 | — | 1.88× | ||
| Q2 25 | 0.87× | 1.10× | ||
| Q1 25 | — | -0.10× | ||
| Q4 24 | 0.05× | 2.02× | ||
| Q3 24 | — | 1.49× | ||
| Q2 24 | — | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARGX
暂无分部数据
AVY
| Materials Group | $1.6B | 72% |
| Solutions Group | $649.2M | 28% |
